Literature DB >> 11331008

Identification of the 6-sulfate binding site unique to alpha-subunit-containing isozymes of human beta-hexosaminidase.

R Sharma1, H Deng, A Leung, D Mahuran.   

Abstract

In humans, beta-hexosaminidase A (alphabeta) is required to hydrolyze GM2 ganglioside. A deficiency of either the alpha- or beta-subunit leads to a severe neurological disease, Tay-Sachs or Sandhoff disease, respectively. In mammals beta-hexosaminidase B (betabeta) and S (alphaalpha) are other major and minor isozymes. The primary structures of the alpha- and beta-subunits are 60% identical, but only the alpha-containing isozymes can efficiently hydrolyze beta-linked GlcNAc-6-SO(4) from natural or artificial substrates. Hexosaminidase has been grouped with glycosidases in family 20. A molecular model of the active site of the human hexosaminidase has been generated from the crystal structure of a family 20 bacterial chitobiase. We now use the chitobiase structure to identify residues close to the carbon-6 oxygen of NAG-A, the nonreducing beta-GlcNAc residue of its bound substrate. The chitobiase side chains in the best interactive positions align with alpha-Asn(423)Arg(424) and beta-Asp(453)Leu(454). The change in charge from positive in alpha to negative in beta is consistent with the lower K(m) of hexosaminidase S, and the much higher K(m) and lower pH optimum of hexosaminidase B, toward sulfated versus unsulfated substrates. In vitro mutagenesis, CHO cell expression, and kinetic analyses of an alphaArg(424)Lys hexosaminidase S detected little change in V(max) but a 2-fold increase in K(m) for the sulfated substrate. Its K(m) for the nonsulfated substrate was unaffected. When alphaAsn(423) was converted to Asp, again only the K(m) for the sulfated substrate was changed, increasing by 6-fold. Neutralization of the charge on alphaArg(424) by substituting Gln produced a hexosaminidase S with a K(m) decrease of 3-fold and a V(max) increased by 6-fold for the unsulfated substrate, parameters nearly identical to those of hexosaminidase B at pH 4.2. As well, for the sulfated substrate at pH 4.2 its K(m) was increased 9-fold and its V(max) decreased 1.5-fold, values very similar to those of hexosaminidase B obtained at pH 3.0, where its betaAsp(453) becomes protonated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331008      PMCID: PMC2910086          DOI: 10.1021/bi0029200

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

1.  Identification of an active acidic residue in the catalytic site of beta-hexosaminidase.

Authors:  R Tse; G Vavougios; Y Hou; D J Mahuran
Journal:  Biochemistry       Date:  1996-06-11       Impact factor: 3.162

2.  Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A.

Authors:  Y Hou; R Tse; D J Mahuran
Journal:  Biochemistry       Date:  1996-04-02       Impact factor: 3.162

3.  The Val192Leu mutation in the alpha-subunit of beta-hexosaminidase A is not associated with the B1-variant form of Tay-Sachs disease.

Authors:  Y Hou; G Vavougios; A Hinek; K K Wu; P Hechtman; F Kaplan; D J Mahuran
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

Review 4.  The final stage of gene expression: chaperones and the regulation of protein fate.

Authors:  J Ashkenas; P H Byers
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

Review 5.  Protein quality control: triage by chaperones and proteases.

Authors:  S Gottesman; S Wickner; M R Maurizi
Journal:  Genes Dev       Date:  1997-04-01       Impact factor: 11.361

Review 6.  Biochemical consequences of mutations causing the GM2 gangliosidoses.

Authors:  D J Mahuran
Journal:  Biochim Biophys Acta       Date:  1999-10-08

7.  Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease.

Authors:  I Tews; A Perrakis; A Oppenheim; Z Dauter; K S Wilson; C E Vorgias
Journal:  Nat Struct Biol       Date:  1996-07

8.  Identification of candidate active site residues in lysosomal beta-hexosaminidase A.

Authors:  M J Fernandes; S Yew; D Leclerc; B Henrissat; C E Vorgias; R A Gravel; P Hechtman; F Kaplan
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

9.  A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease.

Authors:  Y Hou; B McInnes; A Hinek; G Karpati; D Mahuran
Journal:  J Biol Chem       Date:  1998-08-14       Impact factor: 5.157

10.  Structural and functional characterization of Streptomyces plicatus beta-N-acetylhexosaminidase by comparative molecular modeling and site-directed mutagenesis.

Authors:  B L Mark; G A Wasney; T J Salo; A R Khan; Z Cao; P W Robbins; M N James; B L Triggs-Raine
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

View more
  8 in total

1.  An alpha-subunit loop structure is required for GM2 activator protein binding by beta-hexosaminidase A.

Authors:  Maryam Zarghooni; Scott Bukovac; Michael Tropak; John Callahan; Don Mahuran
Journal:  Biochem Biophys Res Commun       Date:  2004-11-19       Impact factor: 3.575

2.  A sensitive fluorescence-based assay for monitoring GM2 ganglioside hydrolysis in live patient cells and their lysates.

Authors:  Michael B Tropak; Scott W Bukovac; Brigitte A Rigat; Sayuri Yonekawa; Warren Wakarchuk; Don J Mahuran
Journal:  Glycobiology       Date:  2009-11-16       Impact factor: 4.313

3.  Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.

Authors:  Brian L Mark; Don J Mahuran; Maia M Cherney; Dalian Zhao; Spencer Knapp; Michael N G James
Journal:  J Mol Biol       Date:  2003-04-11       Impact factor: 5.469

Review 4.  Lending a helping hand, screening chemical libraries for compounds that enhance beta-hexosaminidase A activity in GM2 gangliosidosis cells.

Authors:  Michael B Tropak; Don Mahuran
Journal:  FEBS J       Date:  2007-10       Impact factor: 5.542

5.  A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.

Authors:  Rohita Sharma; Scott Bukovac; John Callahan; Don Mahuran
Journal:  Biochim Biophys Acta       Date:  2003-01-20

6.  Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis.

Authors:  Kazuhiko Matsuoka; Tomomi Tamura; Daisuke Tsuji; Yukie Dohzono; Keisuke Kitakaze; Kazuki Ohno; Seiji Saito; Hitoshi Sakuraba; Kohji Itoh
Journal:  Mol Ther       Date:  2011-04-12       Impact factor: 11.454

7.  Construction of a hybrid β-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo.

Authors:  Michael B Tropak; Sayuri Yonekawa; Subha Karumuthil-Melethil; Patrick Thompson; Warren Wakarchuk; Steven J Gray; Jagdeep S Walia; Brian L Mark; Don Mahuran
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-02       Impact factor: 6.698

8.  In cellulo examination of a beta-alpha hybrid construct of beta-hexosaminidase A subunits, reported to interact with the GM2 activator protein and hydrolyze GM2 ganglioside.

Authors:  Incilay Sinici; Sayuri Yonekawa; Ilona Tkachyova; Steven J Gray; R Jude Samulski; Warren Wakarchuk; Brian L Mark; Don J Mahuran
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.